Report cover image

Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune D

Publisher Coherent Market Insights
Published May 02, 2022
Length 242 Pages
SKU # CMI17213373

Description

Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The Philippines, Malaysia, Singapore, Thailand, Vietnam, Rest of South East Asia, Taiwan, Hong Kong, Macau, Japan, South Korea, India, Australia, China, and Rest of Asia Pacific)) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Antibody drugs are established first-line treatment modalities for a range of cancer and other diseases. On the basis of type, the Middle East and Asia Pacific antibody drugs market is segmented into Monoclonal Antibody, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody.
Monoclonal Antibody are laboratory-produced antibodies designed to recognize and bind to specific receptors found on the surface of cells. Monoclonal Antibody are used in the diagnosis and treatment of various diseases including some types of cancer. Polyclonal antibodies are a heterogeneous mix of antibodies derived from the immune response of multiple B-cells, in which each one recognizes a different epitope on the same antigen. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen. Biosimilar Monoclonal Antibody (mAbs) are part of the biosimilar family. They are large, complex proteins used by the immune system to identify and neutralize foreign bodies such as bacteria, viruses, and others, and are usually administered in the treatment of diseases such as cancer or rheumatoid arthritis.
Market Dynamics
The high prevalence of chronic diseases such as cancer, multiple sclerosis, asthma, rheumatoid arthritis, psoriasis, and others is expected to drive the Middle East and Asia Pacific antibody drugs market growth in the forecast period. For instance, according to the Cancer Country Profile 2020 published by the World Health Organization (WHO), the total number of cancer cases in 2018 in Bahrain was 1,048 with 603 deaths. Moreover, as per the information provided in an article published in the Journal of Clinical Medicine in 2021, Saudi Arabia has the highest prevalence of non-communicable diseases (NCDs) such as cancer, cardiovascular disease, and others, which account for 73% of the country's mortality.
Key features of the study:
This report provides an in-depth analysis of the Middle East and Asia Pacific antibody drugs market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Middle East and Asia Pacific antibody drugs market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include Novartis AG, Amgen, Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Johnson & Johnson Private Limited, Abbvie, Inc., Eli Lilly and Company, GlaxoSmithKline plc., Daiichi Sankyo Company, Limited, Celltrion Healthcare Co., Ltd., Mylan N.V., Boehringer Ingelheim International GmbH., Biocon, and Merck & Co., Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Middle East and Asia Pacific antibody drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Middle East and Asia Pacific antibody drugs market
Detailed Segmentation:
Middle East and Asia Pacific Antibody Drugs Market, By Type:
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
Middle East and Asia Pacific Antibody Drugs Market, By Disease Indication:
Oncology
Neurology
Autoimmune Disorders
Others
Middle East and Asia Pacific Antibody Drugs Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Middle East and Asia Pacific Antibody Drugs Market, By Region:
Middle East
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Kingdom of Saudi Arabia
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
UAE
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Israel
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Iran
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Jordan
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Turkey
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Qatar
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Rest of Middle East
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Asia Pacific
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
South East Asia
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The Philippines
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Malaysia
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Singapore
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Thailand
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Vietnam
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Rest of South East Asia
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Taiwan
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Hong Kong
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Macau
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Japan
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
South Korea
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
India
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Australia
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
China
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Rest of Asia Pacific
By Type
Monoclonal Antibody
Polyclonal Antibody
Bispecific Antibody
Biosimilars
Single Domain Antibody
CAR-T
Anti-idiotype Antibody
By Disease Indication
Oncology
Neurology
Autoimmune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Company Profiles
Novartis AG
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Amgen, Inc.
F. Hoffmann-La Roche Ltd
Pfizer Inc.
Johnson & Johnson Private Limited
AbbVie
Eli Lilly and Company
GlaxoSmithKline plc.
Daiichi Sankyo Company, Limited
Celltrion Healthcare Co., Ltd.
Mylan N.V.
Boehringer Ingelheim International GmbH.
Biocon
Merck & Co., Inc.
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

242 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Disease Indication
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Market Opportunity Map
3. Middle East and Asia Pacific Antibody Drugs Market Insights
Drivers
Restraints
Opportunity
Impact Analysis
Pipeline Analysis
Market Trends
Product Launches
Key Developments
Regulatory Scenario
Government Initiatives
Overview of Clinical and Commercial Manufacturing of Therapeutic Antibody Drugs
Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation
Collaborations & Agreements
Epidemiology
PEST Analysis
4. Middle East and Asia Pacific Antibody Drugs Market – COVID-19 Impact Analysis
COVID-19 Epidemiology
Government Initiative to Combat COVID-19
Overall Impact
5. Middle East and Asia Pacific Antibody Drugs Market, By Type, 2017 - 2030 (US$ Million)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Segment Trends
Monoclonal Antibody
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Polyclonal Antibody
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Bispecific Antibody
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Biosimilars
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Single Domain Antibody
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
CAR-T
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Anti-idiotype Antibody
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
6. Middle East and Asia Pacific Antibody Drugs Market, By Disease Indication, 2017 - 2030 (US$ Million)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Autoimmune Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
7. Middle East and Asia Pacific Antibody Drugs Market, By Distribution Channel, 2017 - 2030 (US$ Million)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
8. Middle East and Asia Pacific Antibody Drugs Market, By Region, 2017 - 2030 (US$ Million)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Region at Trends
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2030, (US$ Million)
Kingdom of Saudi Arabia
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
UAE
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Israel
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Iran
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Jordan
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Turkey
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Qatar
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Rest of Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2030, (US$ Million)
South East Asia
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
The Philippines
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Malaysia
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Singapore
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Thailand
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Vietnam
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Rest of South East Asia
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Taiwan
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Hong Kong
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Macau
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Japan
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
South Korea
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
India
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Australia
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
China
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
Rest of Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Million)
9. Competitive Snapshot
Company Profiles
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Amgen, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
F. Hoffmann-La Roche Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Johnson & Johnson Private Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
AbbVie
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
GlaxoSmithKline plc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Daiichi Sankyo Company, Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Celltrion Healthcare Co., Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Mylan N.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Boehringer Ingelheim International GmbH.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Biocon
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
10. Section
Research Methodology
About us
*Browse 88 market data tables and 47 figures on "Middle East and Asia Pacific Antibody Drugs Market” - forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us